Modulation of neuroimmunity by adenosine and its receptors: Metabolism to mental illness

Metabolism: Clinical and Experimental

Volumn 63, Issue 12, 2014, Pages 1491-1498

  Chiu, Gabriel S ^a   Freund, Gregory G ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Adenosine; Alzheimer's disease; Anxiety; Interleukin 1; Parkinson's disease

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE;

DEGRADATION; HUMAN; IMMUNITY; IMMUNOMODULATION; MENTAL DISEASE; NERVE DEGENERATION; NEUROIMMUNITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; NERVOUS SYSTEM;

ADENOSINE; ANIMALS; HUMANS; MENTAL DISORDERS; MICE; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; RECEPTORS, PURINERGIC P1;

EID: 84922214824     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.09.003     Document Type: Review

References (115)

1. B. Fredholm, M. Abbracchio, G. Burnstock, J. Daly, T. Harden, and K. Jacobson Nomenclature and classification of purinoceptors Pharmacol Rev 46 2 1994 143 156
2. C.M. Portas, M. Thakkar, D.G. Rainnie, R.W. Greene, and R.W. McCarley Role of adenosine in behavioral state modulation: a microdialysis study in the freely moving cat Neuroscience 79 1 1997 225 235
3. A.S. Lin, T.W. Uhde, S.O. Slate, and U.D. McCann Effects of intravenous caffeine administered to healthy males during sleep Depress Anxiety 5 1 1997 21 28
4. G.S. Pereira, J.I. Rossato, J.J.F. Sarkis, M. Cammarota, C.D. Bonan, and I. Izquierdo Activation of adenosine receptors in the posterior cingulate cortex impairs memory retrieval in the rat Neurobiol Learn Mem 83 3 2005 217 223
5. T. Porkka-Heiskanen Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness Science 276 5316 1997 1265 1268
6. J. Huston, H. Haas, F. Boix, and M. Pfister Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats Neuroscience 73 1 1996 99 107
7. H. Hagberg, P. Andersson, J. Lacarewicz, I. Jacobson, S. Butcher, and M. Sandberg Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia J Neurochem 49 1 1987 227 231
8. M.L. Hart, M. Henn, D. Köhler, D. Kloor, M. Mittelbronn, and I.C. Gorzolla Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury FASEB J 22 8 2008 2784 2797
9. J. Kobie, P. Shah, L. Yang, J. Rebhahn, D. Fowell, and T. Mosmann T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5′-adenosine monophosphate to adenosine J Immunol 177 2006 6780 6786
10. S.W. Schoen, M.B. Graeber, M. Reddington, and G.W. Kreutzberg Light and electron microscopical immunocytochemistry of 5'-nucleotidase in rat cerebellum Histochemistry 87 2 1987 107 113
11. S. Gröndal, L. Bindslev, A. Sollevi, and B. Hamberger Adenosine: a new antihypertensive agent during pheochromocytoma removal World J Surg 1988 581 584
12. V. Ralevic, and G. Burnstock Receptors for purines and pyrimidines Pharmacol Rev 50 3 1998 413 492
13. H. Zimmermann Extracellular metabolism of ATP and other nucleotides Naunyn Schmiedeberg's Arch Pharmacol 362 4-5 2000 299 309
14. R. Corriden, and P.A. Insel Basal release of ATP: an autocrine-paracrine mechanism for cell regulation Sci Signal 3 104 2010 re1 12
15. Y. Pankratov, U. Lalo, A. Verkhratsky, and R.A. North Vesicular release of ATP at central synapses Pflugers Arch 452 2006 589 597
16. G. Guidotti ATP transport and ABC proteins Chem Biol 3 9 1996 703 706
17. P. Bodin, and G. Burnstock Purinergic signaling: ATP release Neurochem Res 26 8/9 2001 959 969
18. A. Deussen, M. Stappert, S. Schafer, and M. Kelm Quantification of extracellular and intracellular adenosine production: understanding the transmembranous concentration gradient Circulation 99 15 1999 2041 2047
19. H. Zimmermann Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system Prog Neurobiol 49 1996 589 618
20. H. Zimmermann, and N. Braun Extracellular metabolism of nucleotides in the nervous system J Auton Pharmacol 1996 397 400
21. T.V. Dunwiddie, L. Diao, and W.R. Proctor Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus J Neurosci 17 20 1997 7673 7682
22. S. Latini, and F. Pedata Adenosine in the central nervous system: release mechanisms and extracellular concentrations J Neurochem 79 3 2001 463 484
23. M. Pak, H. Haas, U. Decking, and J. Schrader Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices Neuropharmacology 33 9 1994 1049 1053
24. S. Latini, C. Corsi, F. Pedata, and G. Pepeu The source of brain adenosine outflow during ischemia and electrical stimulation Neurochem Int 1996 3 8
25. S. Schoen, U. Ebert, and W. Löscher 5′-Nucleotidase activity of mossy fibers in the dentate gyrus of normal and epileptic rats Neuroscience 93 2 1999 519 526
26. E.J.M. Grondal, A. Janetzko, and H. Zimmermann Monospecific antiserum against 5'-nucleotidase from Torpedo electric organ: immunocytochemical distribution of the enzyme and its association with Schwann cell membranes Neuroscience 24 1 1988 351 363
27. D. Boison Adenosine as a modulator of brain activity Drug News Perspect 20 10 2007 607 611
28. T. Dunwiddie, and S. Masino The role and regulation of adenosine in the central nervous system Annu Rev Neurosci 2001 31 55
29. J.A. Thorn, and S.M. Jarvis Adenosine transporters Gen Pharmacol 27 4 1996 613 620
30. P.G.W. Plagemann, R.M. Wohlhueter, and C. Woffendin Nucleoside and nucleobase transport in animal cells Biochim Biophys Acta 947 3 1988 405 443
31. T.C. Williams, and S.M. Jarvis Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles Biochem J 274 1991 27 33
32. X. Wu, G. Yuan, C.M. Brett, A.C. Hui, and K.N. Giacomini Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides J Biol Chem 267 1992 8813 8818
33. J.J. Sanchez, G. Monaghan, C. Børsting, G. Norbury, N. Morling, and H.B. Gaspar Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry Ann Hum Genet 71 Pt 3 2007 336 347
34. M.R. Blackburn, and R.E. Kellems Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation Adv Immunol 86 2005 1 41
35. P.W. Kantoff, D.B. Kohn, H. Mitsuya, D. Armentano, M. Sieberg, and J.A. Zwiebel Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer Proc Natl Acad Sci U S A 83 17 1986 6563 6567
36. R.H. Buckley, R.I. Schiff, S.E. Schiff, M.L. Markert, L.W. Williams, and T.O. Harville Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants J Pediatr 130 3 1997 378 387
37. M. Koshibo, H. Kojima, S. Huang, S. Apasov, and M.V. Sitkovshy Memory of extracellular adenosine A2A purinergiv receptor-mediated signaling in murine T cells J Biol Chem 272 41 1997 25881 25889
38. S.G. Apasov, and M.V. Sitkovsky The extracellular versis intracellular mechanisms of inhibition of the TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase Int Immunol 11 2 1999 179 189
39. S. Apasov, J.-F. Chen, P. Smith, and M.V. Sitkovsky A2A receptor dependent and A2A receptor independent effects of extracellular adenosine on murine thymocytes in condition of adenosine deaminase deficiency Blood 95 12 2000 3859 3867
40. S. Apasov, M.R. Blackburn, R.E. Kellems, P.T. Smith, and M.V. Sitkovsky Adenosine deamiase deficiency increases thymic apoptosis and cause defective T cell receptor signaling J Clin Investig 108 1 2001 131 141
41. X. Liu, C.N. Kim, J. Yang, R. Jemmerson, and X. Wang Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 1 1996 147 157
42. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol Rev 53 4 2001 527 552
43. B.B. Fredholm, K. Bättig, J. Holmén, A. Nehlig, and E.E. Zvartau Actions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 1 1999 83 133
44. N. Rebola, R.J. Rodrigues, L.V. Lopes, P.J. Richardson, C.R. Oliveira, and R. a Cunha Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus Neuroscience 133 1 2005 79 83
45. D. Van Calker, M. Müller, and B. Hamprecht Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells J Neurochem 33 5 1979 999 1005
46. I. Hide, W.L. Padgett, K.A. Jacobson, and J.W. Daly A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase Mol Pharmacol 41 2 1992 352 359
47. B.T. Liang, and B. Haltiwanger Adenosine A2A and A2B receptors in cultured fetal chick heart cells: high- and low-affinity coupling to stimulation of myocyte contractility and cAMP accumulation Circ Res 76 1995 242 251
48. T. Kleppisch, and M. Nelson Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase Proc Natl Acad Sci 92 1995 12441 12445
49. G.S. Chiu, P.T. Darmody, J.P. Walsh, M.L. Moon, K.A. Kwakwa, and J.K. Bray Adenosine through the A2A adenosine receptor increases IL-1β in the brain contributing to anxiety Brain Behav Immun 41 2014 218 231 [Epub ahead of print]
50. N. Fujimura, E. Tanaka, S. Yamamoto, M. Shigemori, and H. Higashi Contribution of ATP-sensitive potassium channels to hypoxia hyperpolarization in rat hippocampal CA1 neurons in vitro J Neurophysiol 77 1997 378 385
51. B.L. Fiebich, K. Biber, K. Lieb, D. van Calker, M. Berger, and J. Bauer Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2A-receptors Glia 18 2 1996 152 180
52. K. Biber, K.-N. Klotz, M. Berger, P.J. Gebiche-Harter, and D. van Calker Adenosine A1 receptor mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression J Neurosci 17 13 1997 4956 4964
53. H.E. Tawfik, J. Schnermann, P.J. Oldenburg, and S.J. Mustafa Role of A1 adneosine receptors in regulating of vascular tone Am J Physiol Heart Circ Physiol 288 3 2005 H1411 H1416
54. M.P. Abbracchio, R. Brambilla, S. Ceruti, H.O. Kim, D.K. von Lubitz, and K.A. Jacobson G protein-dependent actioation of phospholipase c by adenosine A3 receptors in rat brain Mol Pharmacol 48 6 1995 1038 1045
55. T. Porkka-Heiskanen, and A.V. Kalinchuk Adenosine, energy metabolism and sleep homeostasis Sleep Med Rev 15 2 2010 123 135
56. Z.H. Németh, D. Bleich, B. Csóka, P. Pacher, J.G. Mabley, and L. Himer Adenosine receptor activation ameliorates type 1 diabetes FASEB J 21 10 2007 2379 2388
57. Q. Dong, H.N. Ginsberg, and B.F. Erlanger Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance Diabetes Obes Metab 3 5 2001 360 366
58. M.R. Blackburn Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice Trends Pharmacol Sci 24 2 2003 66 70
59. A.K. Dhalla, M. Santikul, J.W. Chisholm, L. Belardinelli, and G.M. Reaven Comparison of the antilipolytic effects of an A1 adenosine receptor partial agonist in normal and diabetic rats Diabetes Obes Metab 11 2 2009 95 101
60. P.J. Magistretti, P.R. Hof, and J.L. Martin Adenosine stimulates glycogenolysis in mouse cerebral cortex: a possible coupling mechanism between neuronal activity and energy metabolism J Neurosci 6 9 1986 2558 2562
61. J.M. Kaartinen, S.P. Hreniuk, L.F. Martin, S. Ranta, K.F. LaNoue, and J.J. Ohisalo Attenuated adenosine-sensitivity and decreased adenosine-receptor number in adipocyte plasma membranes in human obesity Biochem J 279 Pt 1 1991 17 22
62. A.A. Jadhav, and A. Jain Elevated adenosine deaminase activity in overweight and obese Indian subjects Arch Physiol Biochem 118 1 2012 1 5
63. P.D. Morrison, M.W. Mackinnon, J.T. Bartrup, P.G. Skett, and T.W. Stone Changes in adenosine sensitivity in the hippocampus of rats with streptozotocin-induced diabetes Br J Pharmacol 105 4 1992 1004 1008
64. D. Boison Adenosine as a neuromodulator in neurological diseases Curr Opin Pharmacol 8 1 2008 2 7
65. R.A. Cunha Neuroprotection by adenosine in the brain: from A(1) receptor activation to A (2A) receptor blockade Purinergic Signal 1 2 2005 111 134
66. C.G. Dulla, and S.A. Masino Physiologic and metabolic regulation of adenosine Mechanisms 2013 87 107
67. D. Boison Adenosine kinase, epilepsy and stroke: mechanisms and therapies Trends Pharmacol Sci 27 12 2006 652 658
68. S. Ferré, K. Fuxe, B.B. Fredholm, M. Morelli, and P. Popoli Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia Trends Neurosci 20 10 1997 482 487
69. R. Corradetti, G.L. Conte, F. Moroni, M.B. Passani, and G. Pepeu Adenosine decreases aspartate and glutamate release from rat hippocampal slices Eur J Pharmacol 104 1-2 1984 19 26
70. J.-F. Chen, K. Xu, J.P. Petzer, R. Staal, Y.-H. Xu, and M. Beilstein Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease J Neurosci 21 2001 1 6
71. W. Bara-Jimenez, A. Sherzai, T. Dimitrova, A. Favit, F. Babbiani, and M. Gillespie Adenosine A2A receptor antagonist treatment of Parkinson's disease Neurology 61 3 2003 293 296
72. M.A. Schwarzschild, L. Agnati, K. Fuxe, J.-F. Chen, and M. Morelli Targeting adenosine A2A receptors in Parkinson's disease Trends Neurosci 29 11 2006 647 654
73. K. Fuxe, D. Marcellino, S. Genedani, and L. Agnati Adenosine A2A receptors, dopamine S2 receptors and their interactions in Parkinson's disease Mov Disord 22 14 2007 1990 2017
74. R. Dungo, and E.D. Deeks Istradefylline: first global approval Drugs 73 2013 875 882
75. C.V. Gomes, M.P. Kaster, A.R. Tomé, P.M. Agostinho, and R.A. Cunha Adenosine receptors and brain diseases: neuroprotection and neurodegeneration Biochim Biophys Acta 1808 5 2011 1380 1399
76. C. Martin, M. Leone, X. Viviand, M.-L. Ayem, and R. Guieu High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock Crit Care Med 28 9 2000 3198 3202
77. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat Rev Neurosci 9 1 2008 46 56
78. D.R. Johnson, J.C. O'Connor, M.E. Hartman, R.I. Tapping, and G.G. Freund Acute hypoxia activates the neuroimmune system, which diabetes exacerbates J Neurosci 27 5 2007 1161 1166
79. C.R. Pugh, M. Fleshner, L.R. Watkins, S.F. Maier, and J.W. Rudy The immune system and memory consolidation: a role for the cytokine IL-1beta Neurosci Biobehav Rev 25 1 2001 29 41
80. G.S. Chiu, D. Chatterjee, P.T. Darmody, J.P. Walsh, D.D. Meling, and R.W. Johnson Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1 J Neurosci 32 2012 13945 13955
81. H. Xu, G. Barnes, Q. Yang, G. Tan, D. Yang, and C. Chou Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Investig 112 12 2003 1821 1830
82. J.S. Damiano, V. Oliveira, K. Welsh, and J.C. Reed Heterotypic interactions among NACHT domains: implications for regulation of innate immune responses Biochem J 381 Pt 1 2004 213 219
83. F. Bauernfeind, G. Horvath, A. Stutz, E.S. Alnemri, K. MacDonald, and D. Speert Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression J Immunol 183 2 2009 787 791
84. J. Tschopp, and K. Schroder NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nature reviews Immunology 10 3 2010 210 215
85. M. Lamkanfi, T.-D. Kanneganti, L. Franchi, and G. Núñez Caspase-1 inflammasomes in infection and inflammation J Leukoc Biol 82 2 2007 220 225
86. F. Di Virgilio Liaisons dangereuses: P2X(7) and the inflammasome Trends Pharmacol Sci 28 9 2007 465 472
87. V. Pétrilli, S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration Cell Death Differ 14 9 2007 1583 1589
88. D. Grigg The worlds of tea and coffee: patterns of consumption GeoJournal 57 2002 283 294
89. A. Smith Effects of caffeine on human behavior Food Chem Toxicol 40 9 2002 1243 1255
90. C.F. Brice, and A.P. Smith Effects of caffeine on mood and performance: a study of realistic consumption Psychopharmacology 164 2 2002 188 192
91. P. Botella, and A. Parra Coffee increases state anxiety in males but not in females Hum Psychopharmacol Clin Exp 18 2 2003 141 143
92. M. Burce, N. Scott, P. Shine, and M. Lader Anxiogenic effects of caffeine in patients with anxiety disorders Arch Gen Psychiatry 49 11 1992 867 869
93. K.S. Kendler, J. Myers, and C.O. Gardner Caffeine intake, toxicity and dependence and lifetime risk of psychiatric and substance use disorders: and epidemiologic and co-twin control analysis Psychol Med 12 2006 1717 1725
94. M. Lucas, F. Mirzaei, A. Pan, O.I. Okereke, W.C. Willett, and E.J. O'Reilly Coffee, caffeine, and risk of depression among women Arch Intern Med 171 17 2011 1571 1578
95. M. Lucas, E.J. O'Reilly, A. Pan, F. Mirzaei, W.C. Willett, and O.I. Okereke Coffee, caffeine, and risk of completed suicide: results from three prospective cohorts of American adults World J Biol Psychiatry 15 5 2014 377 386
96. L.M. Juliano, and R.R. Griffiths A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features Psychopharmacology 176 2004 1 29
97. L.A. Conlay, J.A. Conant, F. deBros, and R. Wurtman Caffeine alters plasma adenosine levels Nature 389 136 1997 136
98. K.A. Jacobson, D.K.J.E. von Lubitz, J.W. Daly, and B.B. Fredholm Adenosine receptor ligands: differences with acute versus chronic treatment Trends Pharmacol Sci 17 3 1996 108 113
99. T.W. Stone, S. Ceruti, and M.P. Abbrachio Adenosine receptors and neurological disease: neuroprotection and neurodegeneration Adenosine Recept Health Dis 2009 535 562
100. American Psychiatric Association diagnostic and statistical manual of mental disorders (DSM-5) 5th ed. 2013
101. A. Rosso, J. Mossey, and C.F. Lippa Caffeine: neuroprotective functions in cognition and Alzheimer's disease Am J Alzheimers Dis Other Demen 23 5 2008 417 422
102. A. Ascherio, S. Zhang, M. Herman, I. Kawach, G. Colditz, and F. Speizer Prospective study of caffeine consumption and risk of Parkinson's disease in men and women Ann Neurol 2001 56 63
103. D.S. Charney, G.R. Heninger, and P.I. Jatlow Increased anxiogenic effects of caffeine in panic disorders Arch Gen Psychiatry 42 3 1985 233 243
104. C. Florio, A. Prezioso, A. Papaioannou, and R. Vertua Adenosine A1 receptors modulate anxiety in CD1 mice Psychopharmacology 136 4 1998 311 319
105. B. Johansson, L. Halldner, T.V. Dunwiddie, S.A. Masino, W. Poelchen, and L. Gimenez-Llort Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor Proc Natl Acad Sci U S A 98 16 2001 9407 9412
106. E. Angulo, V. Casadó, J. Mallol, E.I. Canela, F. Viñals, and I. Ferrer A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation Brain Pathol 13 4 2003 440 451
107. O.P. Dall'Igna, A.L. Da Silva, M.O. Dietrich, A. Hoffmann, R.V. de Oliveira, and D.O. Souza Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-d-aspartate receptor antagonist MK-801 in mice Psychopharmacology 166 3 2003 258 263
108. M. Ikeda, K.B. Mackay, D. Dewar, and J. McCulloch Differential alterations in adenosine A1 and κ1 opioid receptors in the striatum in Alzheimer's disease Brain Res 616 1-2 1993 211 217
109. K.A. Jacobson, and Z.-G. Gao Adenosine receptors as therapeutic targets Nat Rev Drug Discov 5 3 2006 247 264
110. B.G. Frenguelli, G. Wigmore, E. Llaudet, and N. Dale Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus J Neurochem 101 5 2007 1400 1413
111. J.C. Fowler Adenosine antagonists delay hypoxia-induced depression of neuronal activity in hippocampal brain slice Brain Res 490 2 1989 378 384
112. O.P. Dall'Igna, P. Fett, M.W. Gomes, D.O. Souza, R.A. Cunha, and D.R. Lara Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice Exp Neurol 203 1 2007 241 245
113. G.W. Arendash, W. Schleif, K. Rezai-Zadeh, E.K. Jackson, L.C. Zacharia, and J.R. Cracchiolo Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production Neuroscience 142 4 2006 941 952
114. R. Sarges, H. Howard, R. Browne, L. Lebel, and P. Seymour 4-Amino triazolo quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants J Med Chem 33 1990 2240 2254
115. M. El Yacoubi, C. Ledent, M. Parmentier, R. Bertorelli, E. Ongini, and J. Costentin Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice Br J Pharmacol 134 1 2001 68 77